The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Background: Gestational diabetes mellitus (GDM) is associated with a higher risk of important adverse outcomes. Practice varies and the best strategy for identifying and treating GDM is unclear. Aim: To estimate the clinical effectiveness and cost-effectiveness of strategies for identifying and treating women with GDM. Methods: We analysed individual participant data (IPD) from birth cohorts and conducted systematic reviews to estimate the association of maternal glucose levels with adverse perinatal outcomes; GDM prevalence; maternal characteristics/risk factors for GDM; and the effectiveness and costs of treatments. The cost-effectiveness of various strategies was estimated using a decision tree model, along with a value of information analysis to assess where future research might be worthwhile. Detailed systematic searches of MEDLINE®and MEDLINE In-Process & Other Non-Indexed Citations®, EMBASE, Cumulative Index to Nursing and Allied Health Literature Plus, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects, Health Technology Assessment database, NHS Economic Evaluation Database, Maternity and Infant Care database and the Cochrane Methodology Register were undertaken from inception up to October 2014. Results: We identified 58 studies examining maternal glucose levels and outcome associations. Analyses using IPD alone and the systematic review demonstrated continuous linear associations of fasting and post-load glucose levels with adverse perinatal outcomes, with no clear threshold below which there is no increased risk. Using IPD, we estimated glucose thresholds to identify infants at high risk of being born large for gestational age or with high adiposity; for South Asian (SA) women these thresholds were fasting and post-load glucose levels of 5.2 mmol/l and 7.2 mmol/l, respectively and for white British (WB) women they were 5.4 and 7.5 mmol/l, respectively. Prevalence using IPD and published data varied from 1.2% to 24.2% (depending on criteria and population) and was consistently two to three times higher in SA women than in WB women. Lowering thresholds to identify GDM, particularly in women of SA origin, identifies more women at risk, but increases costs. Maternal characteristics did not accurately identify women with GDM; there was limited evidence that in some populations risk factors may be useful for identifying low-risk women. Dietary modification additional to routine care reduced the risk of most adverse perinatal outcomes. Metformin (Glucophage,®Teva UK Ltd, Eastbourne, UK) and insulin were more effective than glibenclamide (Aurobindo Pharma – Milpharm Ltd, South Ruislip, Middlesex, UK). For all strategies to identify and treat GDM, the costs exceeded the health benefits. A policy of no screening/testing or treatment offered the maximum expected net monetary benefit (NMB) of £1184 at a cost-effectiveness threshold of £20,000 per quality-adjusted life-year (QALY). The NMB for the three best-performing strategies in each category (screen only, then treat; screen, test, then treat; and test all, then treat) ranged between –£1197 and –£1210. Further research to reduce uncertainty around potential longer-term benefits for the mothers and offspring, find ways of improving the accuracy of identifying women with GDM, and reduce costs of identification and treatment would be worthwhile. Limitations: We did not have access to IPD from populations in the UK outside of England. Few observational studies reported longer-term associations, and treatment trials have generally reported only perinatal outcomes. Conclusions: Using the national standard cost-effectiveness threshold of £20,000 per QALY it is not cost-effective to routinely identify pregnant women for treatment of hyperglycaemia. Further research to provide evidence on longer-term outcomes, and more cost-effective ways to detect and treat GDM, would be valuable. Study registration: This study is registered as PROSPERO CRD42013004608. Funding: The National Institute for Health Research Health Technology Assessment programme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple imputation using chained equations: Issues and guidance for practice
White, I. R., Royston, P., & Wood, A. M. (2011) · Statistics in Medicine · doi:10.1002/sim.4067 · Cited by 9,792 · cited 2×
“To maximise statistical power and minimise bias due to excluding those with any missing data, we used multivariate multiple imputation, with chained equations to impute missing values for covariables and outcomes for the main analyses.(40) We generated 50 imputed data sets and combined these using Rubin’s rules, using…”
MethodHyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Assessing Bias in Studies of Prognostic Factors
Hayden, J. A., van der Windt, D. A., Cartwright, J. L., Côté, P., & Bombardier, C. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-4-201302190-00009 · Cited by 3,287 · cited 1×
“Quality assessment The risk of bias in the included published studies was assessed using a modified version of the Critical Appraisal Skills Programme(57) (CASP) and Quality in Prognosis Studies (QUIPS) quality assessment tool.(58) These tools are designed to aid the assessment of observational studies of association…”
MethodType 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60731-5 · Cited by 3,253 · cited 2×
“Incidence of type 2 diabetes among women with a history of gestational diabetes mellitus Women with GDM have a sevenfold increase in the risk of developing type 2 diabetes later in life compared with women who were normoglycaemic during pregnancy.(2,229) The estimated incidence of type 2 diabetes among women with a hi…”
BackgroundEffect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
A Note on Robust Variance Estimation for Cluster‐Correlated Data
Williams, R. L. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00645.x · Cited by 2,501
Multiple Imputation of Missing Values
Royston, P. (2004) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0400400301 · Cited by 2,340 · cited 1×
“This method replaces missing values with multiple imputed values based on observed characteristics, and thus assumes that the pattern and values of the missing data are dependent on observable characteristics alone.(231) The main advantage of this method is that it is less likely to yield biased and inefficient estima…”
MethodBoney, C. M., Verma, A., Tucker, R., & Vohr, B. R. (2005) · Pediatrics · doi:10.1542/peds.2004-1808 · Cited by 2,303
Gestational Diabetes and the Incidence of Type 2 Diabetes
Kim, C., Newton, K. M., & Knopp, R. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1862 · Cited by 2,276
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122 · cited 6×
“This estimate is a weighted average of the QALY loss from shoulder dystocia, birth trauma and neonatal death, for which the weights correspond to the relative frequency of each individual outcome from the Crowther and Landon trials.(51,52) The QALY loss for shoulder dystocia in the NICE guidelines(18) includes the uti…”
BackgroundMethodInfluentialCriteria for screening tests for gestational diabetes
Carpenter, M. W., & Coustan, D. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90349-0 · Cited by 1,924
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291
Maternal Obesity and Risk of Gestational Diabetes Mellitus
Chu, S. Y., Callaghan, W. M., Kim, S. Y., Schmid, C. H., Lau, J., England, L. J., & Dietz, P. M. (2007) · Diabetes Care · doi:10.2337/dc06-2559a · Cited by 1,114
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2006) · Diabetes Care · doi:10.2337/diacare.29.s1.06.s43 · Cited by 924
A comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924 · cited 1×
“202.(187) In the NICE updated guideline it was assumed that there was a 0.”
BackgroundProbabilistic Sensitivity Analysis Using Monte Carlo Simulation: A Practical Approach
Doubilet, P., Begg, C. B., Weinstein, M. C., Braun, P., & McNeil, B. J. (1985) · Medical Decision Making · doi:10.1177/0272989x8500500205 · Cited by 860 · cited 1×
“Probability distributions were specified for the model parameters so as to reflect uncertainty in the mean estimates.(252,253) The selection of probability distributions for each parameter was based on well-established literature recommendations(254) and is reported alongside the parameter point estimates for the base…”
MethodThangaratinam, S., Rogozinska, E., Jolly, K., Glinkowski, S., Roseboom, T., Tomlinson, J. W., Kunz, R., Mol, B. W., Coomarasamy, A., & Khan, K. S. (2012) · BMJ · doi:10.1136/bmj.e2088 · Cited by 802 · cited 10×
“Certain maternal characteristics/risk factors, including advancing age and obesity, are associated with increased risk of GDM.”
MethodInfluentialHyperglycemia and Adverse Pregnancy Outcome (HAPO) Study
The HAPO Study Cooperative Research Group (2009) · Diabetes · doi:10.2337/db08-1112 · Cited by 702
Sacks, D. A., Hadden, D. R., Maresh, M., Deerochanawong, C., Dyer, A. R., Metzger, B. E., Lowe, L. P., Coustan, D. R., Hod, M., Oats, J. J. N., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1641 · Cited by 687
Gestational diabetes: The consequences of not treating
Langer, O., Yogev, Y., Most, O., & Xenakis, E. M. J. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.11.039 · Cited by 677
Global estimates of the prevalence of hyperglycaemia in pregnancy
Guariguata, L., Linnenkamp, U., Beagley, J., Whiting, D. R., & Cho, N. H. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.003 · Cited by 664
Childhood Obesity and Metabolic Imprinting
Hillier, T. A., Pedula, K. L., Schmidt, M. M., Mullen, J. A., Charles, M.-A., & Pettitt, D. J. (2007) · Diabetes Care · doi:10.2337/dc06-2361 · Cited by 656
Increased Risk of Cardiovascular Disease in Young Women Following Gestational Diabetes Mellitus
Shah, B. R., Retnakaran, R., & Booth, G. L. (2008) · Diabetes Care · doi:10.2337/dc08-0706 · Cited by 489
Screening criteria for high-risk gestational diabetic patients
O'Sullivan, J. B., Mahan, C. M., Charles, D., & Dandrow, R. V. (1973) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)33833-9 · Cited by 478 · cited 1×
“Previously the aim of diagnosing GDM has been to reduce the risk of perinatal complications through the treatment of hyperglycaemia and to identify women at risk of developing future type 2 diabetes.(166,257) Newly proposed criteria, however, seek to identify infants at risk of future obesity through its association w…”
BackgroundAroda, V. R., Christophi, C. A., Edelstein, S. L., Zhang, P., Herman, W. H., Barrett-Connor, E., Delahanty, L. M., Montez, M. G., Ackermann, R. T., Zhuo, X., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3761 · Cited by 467
The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention
The Diabetes Prevention Program Research Group (2012) · Diabetes Care · doi:10.2337/dc11-1468 · Cited by 436
Intermediate metabolism in normal pregnancy and in gestational diabetes
Di Cianni, G., Miccoli, R., Volpe, L., Lencioni, C., & Del Prato, S. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.390 · Cited by 406
Hartling, L., Dryden, D. M., Guthrie, A., Muise, M., Vandermeer, B., & Donovan, L. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-2-201307160-00661 · Cited by 395
Horvath, K., Koch, K., Jeitler, K., Matyas, E., Bender, R., Bastian, H., Lange, S., & Siebenhofer, A. (2010) · BMJ · doi:10.1136/bmj.c1395 · Cited by 359
collaborators, O. B. O. T. A. D., O’Sullivan, E. P., Avalos, G., O’Reilly, M., Dennedy, M. C., Gaffney, G., & Dunne, F. (2011) · Diabetologia · doi:10.1007/s00125-011-2150-4 · Cited by 307
Self-citationLawlor, D. A., Lichtenstein, P., & Långström, N. (2011) · Circulation · doi:10.1161/circulationaha.110.980169 · Cited by 273
Self-citationEffect of treatment of gestational diabetes mellitus on obesity in the next generation
Gillman, M. W., Oakey, H., Baghurst, P. A., Volkmer, R. E., Robinson, J. S., & Crowther, C. A. (2010) · Diabetes Care · doi:10.2337/dc09-1810 · Cited by 269
High Prevalence of Gestational Diabetes in Women from Ethnic Minority Groups
Dornhorst, A., Paterson, C. M., Nicholls, J. S. D., Wadsworth, J., Chiu, D. C., Elkeles, R. S., Johnston, D. G., & Beard, R. W. (1992) · Diabetic Medicine · doi:10.1111/j.1464-5491.1992.tb01900.x · Cited by 263
Gestational Glucose Tolerance and Risk of Type 2 Diabetes in Young Pima Indian Offspring
Franks, P. W., Looker, H. C., Kobes, S., Touger, L., Tataranni, P. A., Hanson, R. L., & Knowler, W. C. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-0823 · Cited by 253
A. Lawlor, D., Fraser, A., Lindsay, R. S., Ness, A., Dabelea, D., Catalano, P., Davey Smith, G., Sattar, N., & Nelson, S. M. (2010) · Diabetologia · doi:10.1007/s00125-009-1560-z · Cited by 238 · cited 2×
“Macrosomia may be associated with longer-term outcomes, such as childhood obesity, diabetes and metabolic disorders in later life.(4,5,230) The aim was to build the economic model with the flexibility to link to further longer-term adverse outcomes and potentially to extend the model once follow-up data on the childre…”
BackgroundMetformin vs insulin in the management of gestational diabetes: a meta-analysis
Gui, J., Liu, Q., & Feng, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064585 · Cited by 222 · cited 1×
“(PLOS ONE).(171) The search strategies of all five reviews included randomised controlled trials (RCTs), one review also included observational studies which were ineligible in our review and therefore these studies were not considered.”
BackgroundReporting of results from network meta-analyses: methodological systematic review
Bafeta, A., Trinquart, L., Seror, R., & Ravaud, P. (2014) · BMJ · doi:10.1136/bmj.g1741 · Cited by 220 · cited 1×
“Network meta-analysis combines this direct and indirect evidence to improve the estimation of the effectiveness of treatments.(173) Formally, analyses were conducted for each dichotomous outcome using a Bayesian approach, based on the models originally created by Lu and Ades,(174) using the OpenBUGS software: www.”
MethodEthnicity and gestational diabetes in New York City, 1995–2003
Savitz, D., Janevic, T., Engel, S., Kaufman, J., & Herring, A. (2008) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.01763.x · Cited by 194
Maternal adiposity—a determinant of perinatal and offspring outcomes?
Lawlor, D. A., Relton, C., Sattar, N., & Nelson, S. M. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.176 · Cited by 192
Self-citationGriffin, M. E., Coffey, M., Johnson, H., Scanlon, P., Foley, M., Stronge, J., O’Meara, N. M., & Firth, R. G. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00214.x · Cited by 185
Randomized trial of metformin vs insulin in the management of gestational diabetes
Spaulonci, C. P., Bernardes, L. S., Trindade, T. C., Zugaib, M., & Francisco, R. P. V. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.03.022 · Cited by 183
Werner, E. F., Pettker, C. M., Zuckerwise, L., Reel, M., Funai, E. F., Henderson, J., & Thung, S. F. (2012) · Diabetes Care · doi:10.2337/dc11-1643 · Cited by 182
Kjos, S. L., Schaefer-Graf, U., Sardesi, S., Peters, R. K., Buley, A., Xiang, A. H., Bryne, J. D., Sutherland, C., Montoro, M. N., & Buchanan, T. A. (2001) · Diabetes Care · doi:10.2337/diacare.24.11.1904 · Cited by 180
Hyperglycemia and Adverse Pregnancy Outcome study: neonatal glycemia
Metzger, B. E., Persson, B., Lowe, L. P., Dyer, A. R., Cruickshank, J. K., Deerochanawong, C., Halliday, H. L., Hennis, A. J., Liley, H., Ng, P. C., et al. (2010) · Pediatrics · doi:10.1542/peds.2009-2257 · Cited by 179
Makgoba, M., Savvidou, M., & Steer, P. (2012) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2011.03156.x · Cited by 170
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia
(2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.01.024 · Cited by 155
The relationship between maternal glycemia and perinatal outcome
Landon, M. B., Mele, L., Spong, C. Y., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318203ebe0 · Cited by 150 · cited 2×
“> 6 mmol/l at 2 hours post load), although this observation is driven primarily by one study.(61) Association between 1-mmol/l increases in fasting and post-load glucose levels and risk of adverse perinatal outcomes This section examines the trends in adverse perinatal outcomes (see Appendix 2, Figures 52–60) and incr…”
BackgroundMethodGarner, P., Okun, N., Keely, E., Wells, G., Perkins, S., Sylvain, J., & Belcher, J. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70461-7 · Cited by 140
Asemi, Z., Samimi, M., Tabassi, Z., & Esmaillzadeh, A. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.296 · Cited by 119
Maternal Glucose at 28 Weeks of Gestation Is Not Associated With Obesity in 2-Year-Old Offspring
Pettitt, D. J., McKenna, S., McLaughlin, C., Patterson, C. C., Hadden, D. R., & McCance, D. R. (2010) · Diabetes Care · doi:10.2337/dc09-2384 · Cited by 116
Metformin compared with glyburide for the management of gestational diabetes
Silva, J. C., Pacheco, C., Bizato, J., de Souza, B. V., Ribeiro, T. E., & Bertini, A. M. (2010) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2010.04.028 · Cited by 115 · cited 1×
“Trials comparing glibenclamide and metformin Two trials directly compared metformin to glibenclamide (Table 22).(192,213) Figure 29 shows the risk of dichotomous outcomes for glibenclamide treatment compared with metformin treatment, and Figure 30 shows the risk of continuous outcomes for glibenclamide treatment compa…”
ResultLawlor, D. A. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dys209 · Cited by 114 · cited 2×
“By contrast, the outcomes used to develop the IADPSG criteria, which we also used, were chosen to identify offspring at risk of future high adiposity and cardiometabolic risk.(48) Although there is evidence that GDM causes greater adiposity in offspring in later life,(48,49) there is still debate about the validity of…”
ResultSelf-citationGlucose challenge test for detecting gestational diabetes mellitus: a systematic review
van Leeuwen, M., Louwerse, M., Opmeer, B., Limpens, J., Serlie, M., Reitsma, J., & Mol, B. (2012) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2011.03254.x · Cited by 110
Lain, K. Y., Garabedian, M. J., Daftary, A., & Jeyabalan, A. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.02.038 · Cited by 100
Low-Carbohydrate Diet for the Treatment of Gestational Diabetes Mellitus
Moreno-Castilla, C., Hernandez, M., Bergua, M., Alvarez, M. C., Arce, M. A., Rodriguez, K., Martinez-Alonso, M., Iglesias, M., Mateu, M., Santos, M. D., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2714 · Cited by 97
Naylor, C. D. (1996) · JAMA · doi:10.1001/jama.275.15.1165 · Cited by 67
Hartling, L., Dryden, D. M., Guthrie, A., Muise, M., Vandermeer, B., & Donovan, L. (2014) · Diabetic Medicine · doi:10.1111/dme.12357 · Cited by 66 · cited 1×
“The shift in the aim of diagnosing GDM from one of identifying women at risk of type 2 diabetes to one of identifying risk of future offspring obesity is especially important for SAs, because SA women, on average, have infants of markedly lower BW and a reduced risk of LGA than white European women.(18,24) However, lo…”
BackgroundHolt, R. I. G., Goddard, J. R., Clarke, P., & Coleman, M. A. G. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00974.x · Cited by 36
Cited by
A Clinical Update on Gestational Diabetes Mellitus
Sweeting, A., Wong, J., Murphy, H. R., & Ross, G. P. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac003 · Cited by 928
Gestational diabetes mellitus: mechanisms, treatment, and complications
Johns, E. C., Denison, F. C., Norman, J. E., & Reynolds, R. M. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.09.004 · Cited by 828
Gestational diabetes: opportunities for improving maternal and child health
Saravanan, P., Magee, L. A., Banerjee, A., Coleman, M. A., Von Dadelszen, P., Denison, F., Farmer, A., Finer, S., Fox-Rushby, J., Holt, R., et al. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30161-3 · Cited by 428
Daly, B., Toulis, K. A., Thomas, N., Gokhale, K., Martin, J., Webber, J., Keerthy, D., Jolly, K., Saravanan, P., & Nirantharakumar, K. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002488 · Cited by 328
Treatments for gestational diabetes: A systematic review and meta-analysis
Farrar, D., Simmonds, M., Bryant, M., Sheldon, T. A., Tuffnell, D., Golder, S., & Lawlor, D. A. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015557 · Cited by 163
“Hence, we feel that it is important to place a moratorium on further small RCTs in this area and that funders should consider commissioning a multicentre large-scale RCT with adequate power to determine the effect and cost-effectiveness of different packages of care on adverse outcomes in women with GDM.”
MethodSelf-citation
Metadata
- Authors
- Farrar, D., Simmonds, M., Griffin, S., Duarte, A., Lawlor, D. A., Sculpher, M., Fairley, L., Golder, S., Tuffnell, D., Bland, M., Dunne, F., Whitelaw, D., Wright, J., & Sheldon, T. A.
- Venue
- Health Technology Assessment
- Published
- 2016-11
- Volume
- 20
- Issue
- 86
- Pages
- 1-348
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2560666190
- Cited by
- 117
- References
- 61
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.